Metabolic syndrome and bladder cancer

Metabolic syndrome (MS), which is characterised by obesity, insulin resistance ± glucose intolerance, dyslipidaemia, hypertension, pro-inflammatory state and prothrombotic state, is highly prevalent and has been associated with increased risk of malignancy [1, 2]. The relationship of MS and its component risk factors in relation to bladder cancer is still not well defined. Several meta-analyses have been performed to try to elucidate the impact...